Literature DB >> 34509431

Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF Therapy.

Enrico Borrelli1, Domenico Grosso1, Costanza Barresi1, Giorgio Lari1, Riccardo Sacconi1, Carlotta Senni1, Lea Querques1, Francesco Bandello1, Giuseppe Querques2.   

Abstract

PURPOSE: To analyze the morphological characteristics and long-term visual outcomes in eyes with diabetic retinopathy (DR) and diabetic macular edema (DME) treated with anti-vascular endothelial growth factor (anti-VEGF) therapy.
DESIGN: Retrospective clinical cohort study.
METHODS: Patients with a long-term follow-up and evidence of resolved DME in at least 1 visit (study visit) after 5 years of follow-up after the initiation of anti-VEGF therapy were included. At the study visit, structural optical coherence tomography (OCT) scans were reviewed for qualitative features reflecting a distress of the neuroretina or retinal pigment epithelium (RPE). A quantitative topographical assessment of the inner and outer retinal thicknesses was also provided.
RESULTS: A total of 61 eyes (50 patients) were included and were divided into 2 subgroups according to visual acuity (VA) at the study visit, yielding a group of 24 eyes with a VA <20/40 ("poor/intermediate vision" group), and 37 eyes with a VA ≥20/40 ("good vision" group). The external limiting membrane (ELM) and RPE bands were more frequently disrupted or absent in the poor/intermediate vision group (P = .003 and P = .019). Similarly, disorganization of retinal inner layers was more prevalent in the poor/intermediate vision group (P = .013). The foveal and parafoveal outer retinal thicknesses were reduced in eyes with poor/intermediate vision (P = .022 and P = .044). Multivariate stepwise linear regression analysis demonstrated that VA was associated with appearances of the RPE and ELM (P < .0001 and P = .048), foveal and parafoveal outer retinal thicknesses (P = .046 and P = .035).
CONCLUSIONS: Modifications in the outer retina and RPE represent OCT biomarkers of long-term visual outcomes in eyes with DME treated with anti-VEGF.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34509431     DOI: 10.1016/j.ajo.2021.09.002

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Optical coherence tomography angiography metrics in different stages of diabetic macular edema.

Authors:  Ruyi Han; Ruowen Gong; Wei Liu; Gezhi Xu
Journal:  Eye Vis (Lond)       Date:  2022-04-05

2.  Changes in Macular Perfusion After ILUVIEN® Intravitreal Implant for Diabetic Macular Edema: An OCTA Study.

Authors:  Maria Brambati; Enrico Borrelli; Luigi Capone; Lea Querques; Riccardo Sacconi; Marco Battista; Francesco Bandello; Giuseppe Querques
Journal:  Ophthalmol Ther       Date:  2022-01-28

Review 3.  Progress of Imaging in Diabetic Retinopathy-From the Past to the Present.

Authors:  Shintaro Horie; Kyoko Ohno-Matsui
Journal:  Diagnostics (Basel)       Date:  2022-07-11

4.  Factors associated with the recurrence of choroidal neovascularization in pathologic myopia.

Authors:  Ruixia Jing; Yuxia Bo; Lei Gao; Zhen Wang
Journal:  Front Med (Lausanne)       Date:  2022-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.